je.st
news
Tag: study
Supradyn multivitamins/minerals show brain boosting potential: Bayer study
2016-02-23 01:46:24| Chemicals - Topix.net
Short-term and longer-term supplementation with multivitamins and minerals may boost metabolic measures and blood flow in the brain, says a new study funded by Bayer HealthCare - Consumer Care. Because the brain is the most metabolically active organ in the body and micronutrients can modulate energy metabolism and blood flow in the brain, researchers from Northumbria University in England and Bayer HealthCare examined if a single dose of the Supradyn multivitamin/mineral + CoQ10 product affected these parameters.
Tags: show
study
potential
brain
CDC team kicks off Zika study in Brazil focused on Zika
2016-02-22 21:11:26| Biotech - Topix.net
Dr. Erin Staples from the United States' Centers for Disease Control and Prevention speaks before members of Brazil's Health Ministry and the Paraiba state's health secretariat in Joao Pessoa, Brazil, Monday, Feb. 22, 2016. A 16-member team of the U.S. Centers for Disease Control and Prevention is starting work on a "case-control" study aimed at determining whether the Zika virus really does cause babies to be born with the devastating birth defect microcephaly, as Brazilian researchers strongly suspect.
Canadians divided over human role in climate change, study suggests
2016-02-22 15:54:00| Climate Ark Climate Change & Global Warming Newsfeed
CBC: A study co-authored by University of Montreal researchers suggests that while 79 per cent of Canadians do not doubt the reality of climate change, 39 per cent don't believe it is caused by human activity. The researchers, also from four other universities, including Yale, surveyed a total of more than 5,000 Canadians over the last five years. "We asked participants if they believed the Earth was getting warmer partly or mostly due to human activities as an indication of climate change," said...
Mercks Investigational Once-Daily Formulation of ISENTRESS (raltegravir) Meets Primary and Secondary Endpoints in Pivotal Phase 3 Study
2016-02-22 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Results to be Presented at Future Medical Meeting, and Regulatory Submissions Planned for 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced top-line results from the companys Phase 3 pivotal trial, ONCEMRK. ONCEMRK is evaluating an investigational once-daily formulation of ISENTRESS (raltegravir), known as raltegravir 600 mg (to be given as 2 x 600 mg once-daily), for previously untreated HIV-1 infected adults. Language: English Contact: For MerckMedia:Pamela Eisele, 267-305-3558orCarmen de Gourville, 267-305-4195orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
primary
phase
secondary
Advanced Biofuels USA Correspondent Analyzes The Potential For A Reinvigorated US Shale Oil/Gas Industry In Recent Study
2016-02-22 01:24:41| pollutiononline News Articles
Advanced Biofuels USA correspondent Robert E. Kozak analyzes the potential for a reinvigorated US shale oil/gas industry with and without government subsidies; and compares it to the potential for near-term growth of renewable sustainable clean, low greenhouse gas emissions liquid transportation fuels
Tags: advanced
recent
usa
study
Sites : [320] [321] [322] [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] next »